InMed Pharmaceuticals Inc.
INMPharmaceutical Preparations · SIC 2834 · CIK 0001728328
Revenue FY2026
—
Net Income
$(13.0M)
EPS (Basic)
$-3.12
Net Margin
—
ROE
-1168.4%
Total Equity
$1.0M
Shares Out
5M
InMed Pharmaceuticals Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2020–FY2026; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 2 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Vivo Capital
Vivo Capital
$1.2M
0.0%
NEW
Suvretta Capital Management
Suvretta Capital Management
$0.2M
0.0%
NEW
Insider Transactions
Reading stored insider transactions…